Insulin and gall stones: A population case control study in southern Italy

Gut

Volumn 47, Issue 1, 2000, Pages 144-147

  Misciagna, G ^a   Guerra, V ^a   Di Leo, A ^a   Correale, M ^a   Trevisan, M ^b  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Case control study; Epidemiology; Gallstones; Insulin

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GALLSTONE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERINSULINEMIA; INCIDENCE; INSULIN BLOOD LEVEL; INSULIN METABOLISM; ITALY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHOLELITHIASIS; FEMALE; HUMANS; HYPERINSULINISM; INSULIN; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 0033917292     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.47.1.144     Document Type: Article

References (27)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 198S;37:1595-607.
2. Ferrannini E, Haffner SM, Mitchell BD, el al. Hyperinsulinemia: the key feature of cardiovascular and metabolic syndrome. Diabctohgia 1991;34:416-22.
3. Gray RS, Fabsitz RR, Cowan LD, et al. Risk factors clustering in the insulin resistance syndrome. The Strong Heart Study. Am J Epidemiol 1998;14S:869-78.
4. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995;6:164-79.
5. Nakayama F. Cholelithiasis: causes and treatment. Tokyo: IgakuShoin, 1997:11-26.
6. Norton JJ, Smith LR, Hamper E. Diabetes mellitus and gallstones with special reference to insulin assay. Am J Gasiroemerol 1968;50:214-20.
7. Stout RW, Balmer JP, Henry RW, el al. Plasma lipids and gastro-intestinal hormones in subjects with gallstones. Harm Melab Res 1978;10:357-8.
8. Scragg RKR, Calvert GD, Oliver Plasma lipids and insulin in gallstone disease: a case-control study. BMJ 1984;2S9:521-5.
9. Schwüle PO, Hanisch E, Engelhardt W, et al. Basal plasma somatostatin in biliary stone patients. Klin Vi'oehenschr 1984;62:595-7.
10. l"0 Caroli A, Sardeo P, Gasparoni P, et al. Rapporti tra insulina plasmatica e calcolosi biliare nel paziente diabetico. Alinen-a Dicwl Gastroenterol I988;34:205-8.
11. Laakso M, Suhonen M, Julkunen R, et al. Plasma insulin, serum lipids and lipoproteins in gallstone disease in non-insulin dependent diabetic subjects: a case control study. Gut 1990;31:344-7.
12. Pazzi P, Trevisani L, Sartori S. Diabetes and cholelithiasis. Gut 1991;32:1422-3.
13. Haffner SM, Diehl AK, Mitchell BD, et al. Increased prevalence of clinical gallbladder disease in subjects with non-insulin-dependent diabetes mellitus. Am J Epidemiol 1990;132:327-35.
14. Haffner SM, Diehl AK, Valdez R, et al. Clinical gallbladder disease in NIDDM subjects. Relationship to duration of diabetes and severity of glycemia. Diabetes Care 1993;16: 1276-83.
15. Froehlich F, Gonven JJ, Fried Al. Role of nutrient fat and cholecystokinin in regulation of gallbladder emptying in men. Dig Dis Sei 1995;40:528-33.
16. Misciagna G, Leoci C, Elba S, el al. The epidemiology of cholelithiasis in southern Italy. Ear J Gasiroenterol Hepawl 1994;6:937-41.
17. Festi D, Lalloni L, Taroni F, al. Inter- and intra-observer variation in ultrasonographic detection of gallstones: the Multicentie Italian Study on the Epidemiology of Cholelithiasis (MICOL). Eur J Epidemiol 1989;5:51-7.
18. The expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-97.
19. Barbara L, Sama C, Morselli Labate AM, et al. A population study on the prevalence of gallstone disease: the Sirmione study. Hepatology 1987;7:913-17.
20. Nakayama F. Cholelithiasis: causes and treatment. Tokyo: IgakuShoin, 1997;109-11.
21. Misciagna G, Leoci C, Guerra V, el al. Epidemiology of cholelithiasis in Southern Italy. Part II: Risk factors. Eur J Gasiroemcrol Hepatot 1996;8:585-93.
22. Thornton JR, Heaton KV, MacFarlane DG. Plasma lipids, insulin and gallstone risk. Clin Sei 1978;59:831-2.
23. Kono S, Shinchi K, Ikeda N, et al. Prevalence of gallstone disease in relation to smoking, alcohol use, obesity, and glucose tolerance: a study of self-defense officials in Japan. Am J Epidemiol 1992;136:787-94.
24. De Santis A, Attili AF, Corradini SG, el al. Gallstones and diabetes: a case-control study in a free-living population sample. Hepatology 1997;25:787-90.
25. Bennion LJ, Grundy SM. Effects of diabetes mellitus on cholesterol metabolism in man. AT Engl J Med 1977;296: 1365-71.
26. Bjorntorp P. Abdominal obesity and the metabolic syndrome. Ann Med 1992;24:465-8.
27. Haffner SM, Diehl AK, Stern MP, et al. Central adiposity and gallbladder disease in Mexican Americans. Am J Epidemiol 1989;129:587-95.